Breast Cancer News and Research

Latest Breast Cancer News and Research

Women with breast cancer can benefit from web-based programme

Women with breast cancer can benefit from web-based programme

Scientists identify novel protein expressed by breast cancer cells

Scientists identify novel protein expressed by breast cancer cells

National Council for Research on Women honors CINJ breast oncologist

National Council for Research on Women honors CINJ breast oncologist

Cell-based test to discover molecules to treat ER-positive breast cancer

Cell-based test to discover molecules to treat ER-positive breast cancer

FDA clears UELS contactless breast cancer imaging tool

FDA clears UELS contactless breast cancer imaging tool

Novel partnership could transform breast cancer diagnosis

Novel partnership could transform breast cancer diagnosis

Promising results from initial trial of new ultrasonic breast cancer screening

Promising results from initial trial of new ultrasonic breast cancer screening

Early surgical intervention stops seizures and improves quality of life

Early surgical intervention stops seizures and improves quality of life

Older women face increased risk of late stage breast cancer diagnosis

Older women face increased risk of late stage breast cancer diagnosis

March issue of WHO Bulletin available online

March issue of WHO Bulletin available online

Serum taurine may protect against CHD in women with high cholesterol

Serum taurine may protect against CHD in women with high cholesterol

Cancer cons preying on hope, SBS Dateline

Cancer cons preying on hope, SBS Dateline

1.3 million cancer deaths in 2012 in the EU: Report

1.3 million cancer deaths in 2012 in the EU: Report

SIR to showcase latest minimally invasive treatments at 37th annual meeting

SIR to showcase latest minimally invasive treatments at 37th annual meeting

Loss of STAT1 transcription factor causes breast cancer development

Loss of STAT1 transcription factor causes breast cancer development

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer receives FDA approval for lower dose formulation of ANGELIQ

On-site pathology evaluations cut operating time, reduce costs of breast cancer care

On-site pathology evaluations cut operating time, reduce costs of breast cancer care

Cancer survival rates on the rise in Northern Ireland

Cancer survival rates on the rise in Northern Ireland

SWHR, NAMS encourage women to understand benefits and risks of hormone therapy

SWHR, NAMS encourage women to understand benefits and risks of hormone therapy

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept fourth quarter revenue decreases to $0.2 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.